Balance Sheet Align Technology, Inc.

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-11 pm EST			5-day change	1st Jan Change
197.51 ^USD	+0.63%		+22.45%	+26.49%

Feb. 09	Align Technology Shares Rise After HSBC Upgrade	MT
Feb. 09	All or Nothing Week

f75e0057a40ebb.jVbRoBGB3YcdoXvhxSMOLyVeSFimuVkP7K7cnWq4ze8.-mepkEfC7t564wmIiWFMbFwOfCrf7R9dmsvp9Vz9j4bLZonUc--CsFDpOg

Published financial data: ALIGN TECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.47B	3.95B	3.73B	3.86B	4B
Total Revenues	2.47B	3.95B	3.73B	3.86B	4B
Cost of Goods Sold, Total	709M	1.02B	1.1B	1.15B	1.2B
Gross Profit	1.76B	2.94B	2.64B	2.71B	2.8B
Selling General & Admin Expenses, Total	1.2B	1.71B	1.67B	1.7B	1.76B
R&D Expenses	175M	250M	305M	347M	364M
Other Operating Expenses	-	-	53K	-	-
Other Operating Expenses, Total	1.38B	1.96B	1.98B	2.05B	2.13B
Operating Income	387M	976M	657M	657M	676M
Interest And Investment Income	3.12M	3.1M	5.37M	17.26M	20.22M
Net Interest Expenses	3.12M	3.1M	5.37M	17.26M	20.22M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	6.8M	-13.3M	-43.8M	-7M	-21M
Other Non Operating Income (Expenses)	-2.06M	2.82M	-5.1M	-7.4M	-7.87M
EBT, Excl. Unusual Items	395M	969M	613M	660M	667M
Restructuring Charges	-	-	-10.2M	-14.02M	-36.97M
Merger & Related Restructuring Charges	-10.2M	-	-	-	-
Gain (Loss) On Sale Of Investments	-5.89M	-	-	-4.99M	9.98M
Asset Writedown	-	-	-1.8M	-	-
Legal Settlements	-	43.4M	-	-	-30.97M
Other Unusual Items	-	-	-2.3M	-	-
EBT, Incl. Unusual Items	379M	1.01B	599M	641M	609M
Income Tax Expense	-1.4B	240M	237M	196M	188M
Earnings From Continuing Operations	1.78B	772M	362M	445M	421M
Net Income to Company	1.78B	772M	362M	445M	421M
Net Income - (IS)	1.78B	772M	362M	445M	421M
Net Income to Common Incl Extra Items	1.78B	772M	362M	445M	421M
Net Income to Common Excl. Extra Items	1.78B	772M	362M	445M	421M
Per Share Items
Net EPS - Basic	22.55	9.78	4.62	5.82	5.63
Basic EPS - Continuing Operations	22.55	9.78	4.62	5.82	5.63
Basic Weighted Average Shares Outstanding	78.76M	78.92M	78.19M	76.43M	74.88M
Net EPS - Diluted	22.41	9.69	4.61	5.81	5.62
Diluted EPS - Continuing Operations	22.41	9.69	4.61	5.81	5.62
Diluted Weighted Average Shares Outstanding	79.23M	79.67M	78.42M	76.57M	74.99M
Normalized Basic EPS	3.13	7.67	4.9	5.4	5.57
Normalized Diluted EPS	3.12	7.6	4.89	5.39	5.56
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	481M	1.09B	783M	800M	821M
EBITA	401M	993M	673M	674M	694M
EBIT	387M	976M	657M	657M	676M
EBITDAR	510M	1.13B	843M	860M	867M
Effective Tax Rate - (Ratio)	-368.64	23.75	39.64	30.59	30.81
Current Domestic Taxes	64.15M	186M	223M	163M	109M
Current Foreign Taxes	29.4M	42.68M	56.54M	51.31M	56.65M
Total Current Taxes	93.55M	228M	279M	214M	165M
Deferred Domestic Taxes	-13.87M	-31.46M	-67.84M	-19.96M	4.96M
Deferred Foreign Taxes	-1.48B	43.43M	26.12M	1.94M	17.25M
Total Deferred Taxes	-1.49B	11.97M	-41.72M	-18.02M	22.22M
Normalized Net Income	247M	606M	383M	413M	417M
Supplemental Operating Expense Items
Advertising Expense	161M	326M	-	201M	185M
Selling and Marketing Expenses	161M	326M	-	201M	185M
Research And Development Expense From Footnotes	175M	250M	305M	347M	364M
Net Rental Expense, Total	29.25M	44.38M	60M	60.63M	45.93M
Stock-Based Comp., COGS (Total)	4.72M	5.63M	6.44M	7.46M	7M
Stock-Based Comp., R&D Exp. (Total)	15.21M	18.04M	23.8M	30.57M	42.73M
Stock-Based Comp., SG&A Exp. (Total)	78.5M	90.66M	103M	116M	124M
Total Stock-Based Compensation	98.43M	114M	133M	154M	174M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	961M	1.1B	942M	937M	1.04B
Short Term Investments	-	71.97M	57.53M	35.3M	-
Total Cash And Short Term Investments	961M	1.17B	1B	973M	1.04B
Accounts Receivable, Total	658M	897M	860M	903M	996M
Other Receivables	45.24M	-	140M	144M	34.03M
Notes Receivable	5.41M	-	-	-	-
Total Receivables	708M	897M	1B	1.05B	1.03B
Inventory	139M	230M	339M	297M	254M
Prepaid Expenses	14.05M	70.22M	69.12M	52.49M	82.98M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	27.06M	125M	16.76M	77.34M	81.58M
Total Current Assets	1.85B	2.49B	2.42B	2.45B	2.49B
Gross Property Plant And Equipment	1.12B	1.56B	1.8B	1.96B	2.05B
Accumulated Depreciation	-301M	-359M	-450M	-551M	-662M
Net Property Plant And Equipment	817M	1.2B	1.35B	1.41B	1.38B
Long-term Investments	-	134M	41.98M	8.02M	-
Goodwill	445M	419M	408M	420M	443M
Other Intangibles, Total	130M	110M	95.72M	82.12M	103M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.55B	1.53B	1.57B	1.59B	1.56B
Deferred Charges Long-Term	22.8M	31.1M	27.4M	25.1M	25.8M
Other Long-Term Assets, Total	12.35M	17.79M	28.43M	104M	208M
Total Assets	4.83B	5.94B	5.95B	6.08B	6.21B
Liabilities
Accounts Payable, Total	142M	164M	128M	113M	109M
Accrued Expenses, Total	313M	488M	316M	434M	474M
Current Portion of Leases	21.74M	22.72M	26.57M	29.65M	31.06M
Current Income Taxes Payable	30.13M	33.84M	74.32M	38.1M	48.81M
Unearned Revenue Current, Total	778M	1.15B	1.34B	1.43B	1.33B
Other Current Liabilities	40.31M	62.73M	37.8M	23.62M	44.67M
Total Current Liabilities	1.33B	1.92B	1.93B	2.07B	2.04B
Long-Term Leases	64.44M	103M	100M	96.97M	88.21M
Unearned Revenue Non Current	62.55M	137M	161M	138M	102M
Other Non Current Liabilities	143M	156M	160M	152M	134M
Total Liabilities	1.6B	2.32B	2.35B	2.45B	2.36B
Common Stock, Total	8K	8K	8K	7K	7K
Additional Paid In Capital	975M	999M	1.04B	1.16B	1.36B
Retained Earnings	2.22B	2.62B	2.57B	2.45B	2.48B
Comprehensive Income and Other	43.5M	4.33M	-10.28M	21.17M	5.98M
Total Common Equity	3.23B	3.62B	3.6B	3.63B	3.85B
Total Equity	3.23B	3.62B	3.6B	3.63B	3.85B
Total Liabilities And Equity	4.83B	5.94B	5.95B	6.08B	6.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	79.13M	78.8M	76.61M	75.1M	73.6M
ECS Total Common Shares Outstanding	78.86M	78.71M	77.27M	75.08M	73.85M
Book Value / Share	41.01	46.03	46.61	48.36	52.16
Tangible Book Value	2.66B	3.09B	3.1B	3.13B	3.31B
Tangible Book Value Per Share	33.72	39.31	40.1	41.68	44.77
Total Debt	86.18M	125M	127M	127M	119M
Net Debt	-875M	-1.17B	-915M	-854M	-925M
Debt Equivalent Oper. Leases	234M	355M	480M	485M	367M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	76.4M	123M	173M	145M	124M
Inventories - Work In Process, Total	31.39M	51.71M	96.56M	91.26M	73.66M
Inventories - Finished Goods, Total	31.44M	55.29M	69.44M	60.15M	56.25M
Land - (BS)	34.6M	58.87M	58.88M	63.88M	63.88M
Buildings, Total	244M	310M	466M	518M	530M
Machinery, Total	468M	525M	687M	827M	1.01B
Full Time Employees	18.07K	22.54K	23.16K	21.61K	20.94K
Accumulated Allowance for Doubtful Accounts (Supple)	10.24M	9.24M	10.34M	14.89M	19.13M
Order Backlog	873M	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.78B	772M	362M	445M	421M
Depreciation & Amortization - CF	80.14M	92.13M	110M	126M	126M
Amortization of Goodwill and Intangible Assets - (CF)	13.4M	16.6M	16M	16.4M	18.9M
Depreciation & Amortization, Total	93.54M	109M	126M	142M	145M
(Gain) Loss on Sale of Investments - (CF)	5.89M	-	-	4.99M	-5.88M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	98.43M	114M	133M	154M	174M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	12.07M	2.81M	-	-	-
Other Operating Activities, Total	-1.45B	20.41M	32.31M	47.2M	76.45M
Change In Accounts Receivable	-140M	-262M	21.55M	-105M	-153M
Change In Inventories	-29.11M	-112M	-130M	30.17M	25.05M
Change In Accounts Payable	52.21M	19.75M	-36.52M	-7.7M	-843K
Change in Unearned Revenues	228M	463M	242M	86.71M	-80.11M
Change In Income Taxes	-2.8M	12.45M	6.33M	-7.77M	-20.28M
Change in Other Net Operating Assets	21.04M	33.92M	-187M	-4.69M	157M
Cash from Operations	662M	1.17B	569M	786M	738M
Capital Expenditure	-155M	-401M	-292M	-178M	-116M
Cash Acquisitions	-421M	-8M	-12.3M	-	-77.08M
Investment in Marketable and Equity Securities, Total	316M	-197M	93.1M	-18.5M	-62.49M
Other Investing Activities, Total	28.08M	42.99M	-2.21M	278K	235K
Cash from Investing	-232M	-563M	-213M	-196M	-255M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	20.31M	25.62M	26.15M	26.6M	25.28M
Repurchase of Common Stock	-51.12M	-484M	-488M	-615M	-381M
Other Financing Activities, Total	-	-	-40M	-10M	-
Cash from Financing	-30.81M	-458M	-502M	-598M	-356M
Foreign Exchange Rate Adjustments	10.48M	-12.12M	-11.51M	4.67M	-21.15M
Net Change in Cash	410M	139M	-158M	-3.84M	106M
Supplemental Items
Cash Income Tax Paid (Refund)	76.33M	203M	232M	295M	177M
Levered Free Cash Flow	504M	596M	274M	618M	621M
Unlevered Free Cash Flow	504M	596M	274M	618M	621M
Change In Net Working Capital	-225M	-163M	104M	-88.58M	4.67M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.6	11.33	6.91	6.83	6.87
Return on Total Capital	10.24	17.27	10.98	10.98	10.93
Return On Equity %	77.55	22.52	10.01	12.31	11.26
Return on Common Equity	77.55	22.52	10.01	12.31	11.26
Margin Analysis
Gross Profit Margin %	71.33	74.26	70.6	70.1	70.09
SG&A Margin	48.58	43.23	44.84	44.1	44.09
EBITDA Margin %	19.45	27.45	20.96	20.71	20.52
EBITA Margin %	16.2	25.12	18.02	17.44	17.37
EBIT Margin %	15.66	24.7	17.59	17.02	16.89
Income From Continuing Operations Margin %	71.84	19.53	9.68	11.52	10.54
Net Income Margin %	71.84	19.53	9.68	11.52	10.54
Net Avail. For Common Margin %	71.84	19.53	9.68	11.52	10.54
Normalized Net Income Margin	9.99	15.32	10.26	10.68	10.42
Levered Free Cash Flow Margin	20.38	15.07	7.33	16	15.52
Unlevered Free Cash Flow Margin	20.38	15.07	7.33	16	15.52
Asset Turnover
Asset Turnover	0.67	0.73	0.63	0.64	0.65
Fixed Assets Turnover	3.28	3.91	2.92	2.8	2.86
Receivables Turnover (Average Receivables)	4.09	5.08	4.25	4.38	4.21
Inventory Turnover (Average Inventory)	5.64	5.51	3.86	3.63	4.34
Short Term Liquidity
Current Ratio	1.4	1.3	1.26	1.18	1.22
Quick Ratio	1.26	1.08	1.04	0.98	1.02
Operating Cash Flow to Current Liabilities	0.5	0.61	0.3	0.38	0.36
Days Sales Outstanding (Average Receivables)	89.43	71.79	85.85	83.31	86.91
Days Outstanding Inventory (Average Inventory)	64.89	66.29	94.57	100.47	84.33
Average Days Payable Outstanding	57.04	50.39	44.13	39.52	35.19
Cash Conversion Cycle (Average Days)	97.27	87.68	136.3	144.25	136.05
Long Term Solvency
Total Debt/Equity	2.66	3.46	3.52	3.49	3.1
Total Debt / Total Capital	2.6	3.34	3.4	3.37	3
LT Debt/Equity	1.99	2.83	2.79	2.67	2.29
Long-Term Debt / Total Capital	1.94	2.74	2.69	2.58	2.22
Total Liabilities / Total Assets	33.04	39.03	39.45	40.33	38.02
Total Debt / EBITDA	0.17	0.11	0.15	0.15	0.14
Net Debt / EBITDA	-1.72	-1.04	-1.09	-0.99	-1.07
Total Debt / (EBITDA - Capex)	0.24	0.17	0.23	0.19	0.16
Net Debt / (EBITDA - Capex)	-2.46	-1.61	-1.66	-1.25	-1.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.71	59.9	-5.51	3.42	3.54
Gross Profit, 1 Yr. Growth %	1.11	66.48	-10.18	2.8	3.52
EBITDA, 1 Yr. Growth %	-19	125.74	-27.87	2.55	2.61
EBITA, 1 Yr. Growth %	-23.02	147.9	-32.24	0.55	3.07
EBIT, 1 Yr. Growth %	-24.75	152.19	-32.72	0.51	2.77
Earnings From Cont. Operations, 1 Yr. Growth %	301.08	-56.53	-53.17	23.09	-5.32
Net Income, 1 Yr. Growth %	301.08	-56.53	-53.17	23.09	-5.32
Normalized Net Income, 1 Yr. Growth %	-23.34	149.01	-36.7	8.14	1.01
Diluted EPS Before Extra, 1 Yr. Growth %	305.24	-56.76	-52.43	26.03	-3.27
Accounts Receivable, 1 Yr. Growth %	19.52	36.41	-4.18	5.09	10.21
Inventory, 1 Yr. Growth %	24.26	65.35	47.14	-12.35	-14.35
Net Property, Plant and Equip., 1 Yr. Growth %	18.79	47.22	12.26	4.3	-1.73
Total Assets, 1 Yr. Growth %	93.13	23.03	0.1	2.29	2.15
Tangible Book Value, 1 Yr. Growth %	109.29	16.38	0.12	0.99	5.66
Common Equity, 1 Yr. Growth %	140.23	12.02	-0.59	0.81	6.1
Cash From Operations, 1 Yr. Growth %	-11.39	77.07	-51.5	38.16	-6.05
Capital Expenditures, 1 Yr. Growth %	3.48	158.91	-27.22	-39.12	-34.96
Levered Free Cash Flow, 1 Yr. Growth %	24.54	18.24	-54.05	127.32	0.42
Unlevered Free Cash Flow, 1 Yr. Growth %	24.54	18.24	-54.05	127.32	0.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.12	28.15	22.92	-1.15	3.48
Gross Profit, 2 Yr. CAGR %	10.35	29.74	22.28	-3.96	3.16
EBITDA, 2 Yr. CAGR %	-3.97	35.22	27.6	-14.15	2.58
EBITA, 2 Yr. CAGR %	-7.93	38.14	29.61	-17.63	1.81
EBIT, 2 Yr. CAGR %	-8.9	37.76	30.26	-17.95	1.63
Earnings From Cont. Operations, 2 Yr. CAGR %	110.64	32.05	-54.88	-24.07	7.95
Net Income, 2 Yr. CAGR %	110.64	32.05	-54.88	-24.07	7.95
Normalized Net Income, 2 Yr. CAGR %	-7.12	37.66	25.54	-17.46	4.52
Diluted EPS Before Extra, 2 Yr. CAGR %	113.42	32.37	-54.64	-22.57	10.41
Accounts Receivable, 2 Yr. CAGR %	22.4	27.69	14.33	0.35	7.62
Inventory, 2 Yr. CAGR %	58.19	43.34	55.98	13.56	-13.36
Net Property, Plant and Equip., 2 Yr. CAGR %	25.21	32.25	28.56	8.21	1.24
Total Assets, 2 Yr. CAGR %	53.4	54.15	10.97	1.19	2.22
Tangible Book Value, 2 Yr. CAGR %	50.69	56.07	7.94	0.55	3.3
Common Equity, 2 Yr. CAGR %	60.66	64.05	5.53	0.11	3.42
Cash From Operations, 2 Yr. CAGR %	9.26	25.26	-7.32	-18.14	13.93
Capital Expenditures, 2 Yr. CAGR %	-16.71	63.68	37.27	-33.44	-37.07
Levered Free Cash Flow, 2 Yr. CAGR %	40.41	21.35	-26.29	1.87	51.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	40.41	21.35	-26.29	1.87	51.08
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.82	26.2	15.77	16.04	0.39
Gross Profit, 3 Yr. CAGR %	16.44	26.56	14.77	15.37	-1.53
EBITDA, 3 Yr. CAGR %	6.54	27.68	9.66	18.49	-8.89
EBITA, 3 Yr. CAGR %	3.64	28.08	8.95	18.93	-11.24
EBIT, 3 Yr. CAGR %	3.07	27.91	8.49	19.3	-11.55
Earnings From Cont. Operations, 3 Yr. CAGR %	97.25	24.48	-6.53	-36.95	-18.28
Net Income, 3 Yr. CAGR %	97.25	24.48	-6.53	-36.95	-18.28
Normalized Net Income, 3 Yr. CAGR %	2.99	28.38	6.25	19.27	-11.71
Diluted EPS Before Extra, 3 Yr. CAGR %	99.32	25.35	-5.89	-36.24	-16.61
Accounts Receivable, 3 Yr. CAGR %	26.59	26.9	16.03	11.16	3.53
Inventory, 3 Yr. CAGR %	63.79	60.54	44.6	28.71	3.37
Net Property, Plant and Equip., 3 Yr. CAGR %	32.82	32.15	25.22	19.9	4.79
Total Assets, 3 Yr. CAGR %	39.37	42.52	33.49	8	1.51
Tangible Book Value, 3 Yr. CAGR %	35.65	38.26	34.6	5.57	2.23
Common Equity, 3 Yr. CAGR %	40.97	42.46	38.82	3.93	2.07
Cash From Operations, 3 Yr. CAGR %	14.72	28.34	-8.7	5.87	-14.29
Capital Expenditures, 3 Yr. CAGR %	-7.49	21.56	24.93	4.68	-33.95
Levered Free Cash Flow, 3 Yr. CAGR %	49.85	32.6	-12.21	7.06	1.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	49.85	32.6	-12.21	7.06	1.38
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.93	29.63	20.44	14.45	10.69
Gross Profit, 5 Yr. CAGR %	22.46	29.2	18.74	13.34	9.96
EBITDA, 5 Yr. CAGR %	18.4	31.48	14.51	8.94	6.7
EBITA, 5 Yr. CAGR %	16.26	31.54	13.34	7.35	5.94
EBIT, 5 Yr. CAGR %	15.47	31.44	13.19	7.1	5.6
Earnings From Cont. Operations, 5 Yr. CAGR %	65.27	32.41	9.34	2.15	-0.99
Net Income, 5 Yr. CAGR %	65.27	32.41	9.34	2.15	-0.99
Normalized Net Income, 5 Yr. CAGR %	16.25	32.1	11.15	7.59	5.46
Diluted EPS Before Extra, 5 Yr. CAGR %	66.15	32.98	10.25	3.38	0.32
Accounts Receivable, 5 Yr. CAGR %	32.91	29.39	21.54	15.53	12.59
Inventory, 5 Yr. CAGR %	48.22	53.37	60.62	39.78	17.81
Net Property, Plant and Equip., 5 Yr. CAGR %	43.04	47.02	31.1	22	15.01
Total Assets, 5 Yr. CAGR %	33.04	33.6	27.23	24.27	19.97
Tangible Book Value, 5 Yr. CAGR %	28.17	27.64	23.8	21.72	21.08
Common Equity, 5 Yr. CAGR %	30.7	29.48	25.55	23.71	23.4
Cash From Operations, 5 Yr. CAGR %	22.71	36.48	5.34	7.21	-0.24
Capital Expenditures, 5 Yr. CAGR %	23.72	41.55	8.33	-4.46	-5.04
Levered Free Cash Flow, 5 Yr. CAGR %	19.93	33.4	12.82	19.33	8.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.93	33.4	12.82	19.33	8.94